Compare Aptos (APT) vs Bio Protocol (BIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aptos vs Bio Protocol — how do they compare? Aptos trades at Rp10,121 (market cap Rp8,61T, Rp395,38M 24h volume), while Bio Protocol trades at Rp443.15 (market cap Rp1,01T, Rp174,27M 24h volume). The key difference: Aptos is far larger — about 8.5× Bio Protocol's market cap, and Aptos's circulating supply is 857,4M / 2,1B APT (41%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 33 Days and Bio Protocol for 17 Days on average.
| APT | BIO | |
|---|---|---|
Market Cap | Rp8,61T | Rp1,01T |
Volume (24h) | Rp395,38M | Rp174,27M |
Circulating Supply | 857,4M / 2,1B APT (41%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 33 Days | 17 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aptos (APT) is currently trading at Rp10,023 with a market cap of Rp8.6T, showing bearish technical signals across moving averages while oscillators remain neutral. The token is trading near its pivot point of Rp10,077 with key support at Rp9,820 and resistance at Rp10,260. With only 41% of the maximum 2.1M APT supply in circulation, tokenomics suggest gradual distribution over time.
Overall outlook remains cautious with bearish technical momentum despite oversold RSI conditions. Key opportunities include potential bounce from support levels, while major risks involve continued downward pressure and limited fundamental catalysts. Investors should monitor network adoption metrics and trading volume patterns closely.
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Aptos
Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.
Read more on APT →About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →
